Tobramycin Solution
Product Images NDC 59651-129
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 59651-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Relative Change From Baseline In Fev1% Predicted (Tobramycin Fig1)
Figure 2: Absolute Change From Baseline In Log10 Cfus (Tobramycin Fig2)
Figure A (Tobramycin Fig3)
Figure B (Tobramycin Fig4)
Figure C (Tobramycin Fig5)
Figure D (Tobramycin Fig6)
Figure E (Tobramycin Fig7)
Figure F (Tobramycin Fig8)
Figure G (Tobramycin Fig9)
Figure H (Tobramycin Fig10)
Figure I (Tobramycin Fig11)
Figure J (Tobramycin Fig12)
Figure K (Tobramycin Fig13)
Figure L (Tobramycin Fig14)
Figure M (Tobramycin Fig15)
Figure N (Tobramycin Fig16)
Figure O (Tobramycin Fig17)
Figure P (Tobramycin Fig18)
Figure Q (Tobramycin Fig19)
Package Label-principal Display Panel (300 mg per 5 mL)
Package Label-principal Display Panel (300 mg per 5 mL)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.